PUBLICATIONS
In 2022, the Global Health Registry formally merged with the Cost-Effectiveness Analysis (CEA) Registry. This site only contains data through 2020 publications. For the most up-to-date data, please visit the new database: https://cear.tuftsmedicalcenter.org/
As part of CEVR’s Global Health Initiative, all available data from cost-per-DALY publications remain free of charge: https://cear.tuftsmedicalcenter.org/registry/download
The Model Clearinghouse on this site is still active and monitored.
Publications in Academic Journals
2020
Feng X, Kim DD, Cohen JT, Neumann PJ, Ollendorf DA. Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter? Int J Technol Assess Health Care. 2020; 36(2):96-103. [PMID 32340631]
Kim DD, Silver MC, Kunst N, Cohen JT, Ollendorf DA, Neumann PJ. Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018 [published online ahead of print, 2020 Jul 22]. Pharmacoeconomics. 2020;10.1007/s40273-020-00942-2. [PMID 32696192]
Leech AA, Kim DD, Cohen JT, Neumann PJ. Are low and middle-income countries prioritizing high-value healthcare interventions? BMJ Glob Health. 2020; 5:e001850. [PMID 32133187]
Panzer AD, Emerson JG, D'Cruz B, et al. Growth and capacity for cost-effectiveness analysis in Africa. Health Econ. 2020; Epub ahead of print. [PMID 32412153]
2019
Butt T, Liu GG, Kim DD, Neumann PJ. Taking stock of cost-effectiveness analysis of healthcare in China. BMJ Glob Health. 2019;4(3):e001418. [PMID 32412153]
Emerson J, Panzer A, Cohen JT, et al. Adherence to the iDSI reference case among published cost-per-DALY averted studies. PLoS One. 2019;14(5): e0205633. [PMID 31042714]
2018
Leech AA, Kim DD, Cohen JT, Neumann PJ. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Value Health. 2018;21(7):759–61 [PMID 30005746]
Neumann PJ, Anderson JE, Panzer AD, et al. Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures. Gates Open Res. 2018;2:5. [PMID 29431169]
2017
Bilinski A, Neumann P, Cohen J, Thorat T, McDaniel K, Salomon JA. When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs. PLoS Med. 2017;14(10):e1002397. [PMID 28847014]
Cohen JT, Neumann PJ, Wong JB. A Call for Open-Source Cost-Effectiveness Analysis. Ann Intern Med. 2017;167(6):432-433. [PMID 29028754]
Cohen JT, Wong JB. Can economic model transparency improve provider interpretation of cost-effectiveness analysis? A response. Med Care. 2017;55(11):912–914. [PMID 29028754]
2016
Neumann PJ, Thorat T, Zhong Y, et al. A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted. PLoS One. 2016;11(12):e0168512. [PMID 28005986]
Teerawattananon Y, Tantivess S, Yamabhai I, et al. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh. Health Res Policy Syst. 2016;14(1):86. [PMID 27912780]
Technical Reports
Emerson, J. and Kim, D.D. (2018). Disability-Adjusted Life Year Conversion, Case Study #1: HIV Cases to DALYs. Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA [Link to download]
Ma, S. and Ollendorf, D. Disability-Adjusted Life Year Conversion, Case Study #2: Dengue Cases to DALYs. Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA [Link to download]
Ma, S. and Ollendorf, D. Disability-Adjusted Life Year Conversion, Case Study #3: Tuberculosis Cases to DALYs. Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA [Link to download]
Ma, S. and Ollendorf, D. Disability-Adjusted Life Year Conversion, Case Study #4: Coronary Heart Disease Cases to DALYs. Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA [Link to download]
Ma, S. and Ollendorf, D. Disability-Adjusted Life Year Conversion, Case Study #5: Postpartum Hemorrhage Cases to DALYs. Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA [Link to download]